-

Elanco, VetNOW Collaborate to Expand Access to Veterinary Care, Relieve Impact of COVID-19

While COVID-19 mitigations drive veterinary offices to adopt alternative approaches to care, access to telemedicine offers an innovative option that has long-term potential to strengthen connection to veterinary clinics

GREENFIELD, Ind.--(BUSINESS WIRE)--Today, Elanco Animal Health Incorporated (NYSE: ELAN) and VetNOW announce a collaboration providing veterinarians access to an industry-leading telemedicine platform so they can maintain service to animals and owners – including specialist consultations - during a time when the industry is challenged to find new ways to connect.

“The practice of veterinary medicine is changing, and COVID-19 is catalyzing that change. Clinics need that innovation right now, but it must be able to help their practices long-term,” said Jeff Simmons, Elanco president and CEO. “VetNOW is a global leader in telemedicine, which facilitates closer relationships with pet owners, meeting them where they are. Veterinarians are the center of all we do at Elanco, and telemedicine keeps them at the center of pets’ lives.”

Through a collaboration with Elanco, veterinarians in the US and Canada enrolling in VetNOW can access the first two months of service free. Providing a full-scale digital ecosystem, VetNOW helps veterinarians continue to provide clients many of their practice services while adhering to social distancing and industry practice recommendations.

Dr. Apryle Horbal, a veterinary pioneer who is one of 21 board-certified specialists in her field, started VetNOW to address the need for specialists for her state-of-the-art veterinary hospital. Since then, VetNOW has grown into a virtual care platform providing veterinary telemedicine services using proprietary, high-definition technology.

VetNOW allows veterinarians and veterinary clinics to offer their clients unlimited virtual follow-ups, prescriptions, and urgent care in real-time via video or chat. Additionally, VetNOW allows general practice veterinarians to connect with globally recognized specialists in fields such as critical care, oncology, neurology, and cardiology. Designed for both small animal and large animal veterinarians, VetNOW services are accessible via Internet connection in a city, suburb or farm.

While today’s situation provides a unique stimulus for veterinarians to engage in telemedicine, there is application beyond the current environment when considering the segment of pet owners that do not regularly visit a veterinary clinic, the continued shift toward convenience throughout our society, and advances in technology to enhance the experience. This collaboration is the latest example of Elanco’s commitment to helping support the needs of animals.

“Every day is a challenge for veterinary practices right now, which is why we are proud to offer the immediate ability for the veterinary community to access their patients and clients through VetNOW anywhere and anytime,” said Dr. Apryle Horbal, VetNOW’s founding CEO and a board-certified equine veterinary dental specialist. “We’ve seen a dramatic increase in demand across the entire US and Canada since the Covid-19 crisis began, and our weekly onboarding sessions have more than tripled. This partnership will ensure that more veterinarians keep their doors open during this difficult time and that we are able to provide reassurance that all animals can safely receive quality care when they need it most.”

VetNOW is fully accredited by the Healthcare Information Management and Systems Society (HIMSS), and is compliant within the Veterinary Client Patient Relationship (VCPR).

“Even before COVID-19, we were seeing a shift in how pet owners approached care. For example, 30 percent of pet owners in the US don’t regularly see a veterinarian,” said Dr. Tony Rumschlag, head of Consulting Veterinarians for Elanco. “So, telemedicine can be a tool to meet pet owners’ changing expectation of pet care, ultimately facilitating more connectivity between Elanco, pets and veterinarians. This is an opportunity for us to help our veterinarians address critical needs both immediately, and over the long term.”

To learn more, veterinarians should contact their Elanco sales representative or visit vetnow.com/Elanco.

ABOUT ELANCO

Elanco (NYSE: ELAN) is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries. With a 65-year heritage, we rigorously innovate to improve the health of animals and benefit our customers, while fostering an inclusive, cause-driven culture for more than 5,800 employees. At Elanco, we’re driven by our vision of food and companionship enriching life - all to advance the health of animals, people and the planet. Learn more at www.elanco.com.

Elanco and the diagonal bar logo are trademarks of Elanco and its affiliates.

© 2020 Elanco

Contacts

Media Contact: Keri S. McGrath +1.317.370.8394 mcgrath_happeks@elanco.com
Investors Contact: Jim Greffet +1.317.383.9935 greffet_james_f@elanco.com

Elanco Animal Health Incorporated Logo
Elanco Animal Health Incorporated Logo

Elanco Animal Health Incorporated

NYSE:ELAN

Release Versions

Contacts

Media Contact: Keri S. McGrath +1.317.370.8394 mcgrath_happeks@elanco.com
Investors Contact: Jim Greffet +1.317.383.9935 greffet_james_f@elanco.com

More News From Elanco Animal Health Incorporated

Elanco to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 8-10, 2024. Jeff Simmons, president and CEO, will represent the company and respond to questions from analysts on Tuesday, January 9, 2024 at 3:00 p.m. PST (6:00 PM EST). A live audio webcast will be available in the “Events and Presentations” section of Elanco’s investor website. A replay will be available for approximately 30 days....

Elanco to Participate in Evercore ISI 6th Annual HealthCONx Conference

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Evercore ISI 6th Annual HealthCONx Conference, November 28-29, 2023. Todd Young, Executive Vice President and CFO, will participate in a fireside chat on Wednesday, November 29 at 8:20 a.m. ET. A live audio webcast will be available in the “Events and Presentations” section of Elanco’s investor website. A replay will be available for approximately 30 days. ABOUT ELANCO Elanco Animal Health Incorpor...

Elanco Animal Health Reports Third Quarter 2023 Results

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported financial results for the third quarter of 2023, provided guidance for the fourth quarter of 2023, and updated guidance for the full year 2023. “Elanco delivered a strong third quarter across both pet health and farm animal, with revenue, adjusted EBITDA, and adjusted EPS growth. Constant currency revenue growth of 5 percent was driven by accelerating contribution from innovation, stabilizing core v...
Back to Newsroom